FP 008Alternative Names: FP008
Latest Information Update: 12 Jan 2016
At a glance
- Originator Foresee Pharmaceuticals
- Class Small molecules
- Mechanism of Action Insulin-like growth factor I inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Diabetic retinopathy
Most Recent Events
- 12 Jan 2016 Early research in Diabetic retinopathy in USA (Intravitreous) prior to January 2016 (Foresse Pharmaceuticals pipeline, January 2016)